Pulmonary aspergillosis associated to COVID-19

Authors

  • Aurelia Cebotaru IP Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, R. Moldova, IMSP Institutul de Ftiziopneumologie „Chiril Draganiuc”, Chişinău, R. Moldova
  • OxanaMunteanu IP Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, R. Moldova
  • Eugenia Scutaru IP Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, R. Moldova
  • Victor Botnaru IP Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, R. Moldova

DOI:

https://doi.org/10.52692/1857-0011.2021.1-69.34

Keywords:

fungal infection, aspergillosis

Abstract

Infection with novel coronavirus (SARS-CoV-2) remains one of the most important pandemics till present, becoming an equation with several unknowns, one of them being the associated fungal infections. Pulmonary mycoses have an increased incidence and mortality, the most common germ identified among cases of COVID-19 is Aspergillus spp. Due to discrepancies in defining and diagnostic criteria, but also nonspecific clinical-imaging manifestations, COVID-19-associated pulmonary aspergillosis remains a diagnostic and management challenge

Author Biographies

Aurelia Cebotaru, IP Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, R. Moldova, IMSP Institutul de Ftiziopneumologie „Chiril Draganiuc”, Chişinău, R. Moldova

2

OxanaMunteanu, IP Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, R. Moldova

dr. în şt. med., conf. univ

Eugenia Scutaru, IP Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, R. Moldova

asist. univ

Victor Botnaru, IP Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, R. Moldova

dr. hab. în şt. med., prof. univ

Published

2021-05-11

Issue

Section

Research Article